Elior UK has announced that Catherine Roe has taken the decision to step down from her role as Chief Executive Officer of Elior UK. Michal Seal, currently Managing Director Healthcare, has been appointed to succeed her.
Catherine Roe’s decision marks the conclusion of an outstanding career within the Elior Group, to which she has devoted more than twenty years of professional commitment, including twelve years leading Elior UK. Throughout this time, Catherine has embodied a style of leadership that has been both demanding and deeply people-focused, making a significant contribution to the transformation and reputation of the business. The company has achieved significant growth during Catherine’s tenure as CEO, both in terms of revenue and profitability.
To ensure the smoothest possible transition, Catherine Roe will remain with Elior until 30th September 2026 and work closely with Michal Seal during this time.
Michal Seal has established a strong reputation as a strategic, commercially astute and results-driven leader, recognised for building high-performing teams and delivering sustained business growth. Most recently, she has successfully returned the UK Healthcare business to sustained profitability through a clear focus on growth, client retention, operational efficiency and disciplined cost management.
Prior to joining Elior, Michal Seal spent more than seven years with SSP Group, where she has played a key role in driving market-leading sales performance and profitability via innovation, a relentless commercial focus and strategic brand development.
Her appointment marks an exciting new chapter for Elior UK.
